Mylan, Tacrolimus Capsules 0.5 mg, 100 count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgant...

FDA Drug Recall #D-066-2013 — Class II — June 29, 2012

Recall Summary

Recall Number D-066-2013
Classification Class II — Moderate risk
Date Initiated June 29, 2012
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Mylan LLC.
Location Caguas, PR
Product Type Drugs
Quantity 15181 bottles.

Product Description

Mylan, Tacrolimus Capsules 0.5 mg, 100 count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-2045-01

Reason for Recall

Failed USP Content Uniformity Requirements: OOS result reported on retained samples.

Distribution Pattern

Natiowide

Lot / Code Information

Lots: 3027684 Exp. 5/13, 3027688 Exp. 6/13 2002157 Exp. 9/12

Other Recalls from Mylan LLC.

Recall # Classification Product Date
D-0441-2017 Class II Temozolomide Capsules, 100 mg, packaged in a) 5... Dec 20, 2016
D-0444-2017 Class II Temozolomide Capsules, 250 mg, 5-count bottles,... Dec 20, 2016
D-0443-2017 Class II Temozolomide Capsules, 180 mg, packaged in a) 5... Dec 20, 2016
D-0442-2017 Class II Temozolomide Capsules, 140 mg, packaged in a) 5... Dec 20, 2016

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.